Cannabis Report
Home > Boards > US OTC > Alternative Energy >

United Health Products, Inc. (UEEC)

UEEC RSS Feed
Add UEEC Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 9/17/2018 9:59:35 PM - Followers: 39 - Board type: Free - Posts Today: 0

United Health Products, Inc.

 

About United Health Products, Inc.

United Health Products, Inc. (UEEC) develops, manufactures, and markets a patented hemostatic gauze for the healthcare and wound care sectors. The product, HemoStyp(R), is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products, Inc. visit: www.unitedhealthproductsinc.com.

UEEC Security Details
Share Structure
Market Value1 $16,300,445 a/o Jun 18, 2014
Shares Outstanding 102,647,640 a/o Apr 15, 2014
Float 82,554,000 a/o Dec 31, 2012
Authorized Shares 150,000,000 a/o Mar 31, 2013
Par Value No Par Value

http://www.otcmarkets.com/stock/UEEC/profile
 

Who we are...

United Health Products develops, manufactures, and markets innovative products based on our proprietary hemostatic gauze core technology. Our products are distributed under the brand name HemoStyp®, and other private label names, to the trauma, dental, dialysis, and veterinary markets.

We are customer driven. We distribute our products worldwide and support our partners with ideas and solutions that will help them manage the health and safety of the people they serve. United Health Products is based in Westbury, New York and
our common stock trades under the symbol “UEEC". More about our company...

What we do...

We produce HemoStyp®, a bio-absorbable sterile gauze that will promote hemostasis almost instantly when applied to a cut or open wound. It is a patented hemostatic agent registered with the FDA to help control bleeding.

HemoStyp® contains no harmful chemicals, additives, or animal by-products and is easily removed from the wound with water or saline without compromising coagulation.

HemoStyp® is available in multiple sizes and configurations
to help control most types of bleeding including: abrasions, lacerations, and major cuts; nose bleeds; dental surgeries;
post dialysis treatment; and puncture wounds.
More about our products...


HemoStyp® is a water soluable hemostatic gauze that will produce hemostasis almost instantly when placed on a cut or open wound.
It does not contain harmful chemicals or animal by-products and is FDA registered to help stop bleeding. Once bleeding has stopped, HemoStyp® is easily removed from the wound with water or saline solution without compromising hemostasis.

HemoStyp® is extremely effective, inexpensive, and easy to use.
It is hypoallergenic and bacteriostatic and is available in multiple sizes and configurations to suit various needs and applications.


United Health Products, Inc. (UEEC) was formed to develop, produce, and market proprietary wound care products. Our core technology is a hemostatic gauze that provides the means to control bleeding from cuts and open wounds with a cost effective, high efficiency product.

This innovative technology is derived from regenerated oxidized cellulose and marketed under the trade name HemoStyp®. It is an effective, all natural hemostatic agent registered with the FDA to help control bleeding from open wounds and body cavities.

HemoStyp® is available in multiple sizes and configurations to suit various market segments and, in a healthcare sector shifting toward providing high quality care at affordable cost, offers an appealing alternative to higher priced competitive products. In addition to general military and civilian applications, the company has recently introduced Hemostyp® to the sports medicine, veterinary, dental surgery and dialysis markets.

UEEC's Chairman and CEO, Dr. Phillip Forman, has over 30 years of experience in wound care management. He leads an experienced executive management team with proven ability to develop, integrate, and grow brands in the healthcare industry. Under Dr. Forman's leadership the company will focus on market expansion, distribution, and brand awareness through:

• New contracts and strategic partnerships
• Effectively targeted marketing and advertising
• Sales excellence
• Outstanding customer support
• Key acquisitions and
• Innovative product development



New Products

We have added new configuations of our patented hemostatic gauze to our product line. The products were developed to address the specific needs of new market segments and of our existing customers, including the U.S. Military. The new products include:

Dental Gauze for oral surgery,

Four versions of Trauma Gauze™ for battlefield trauma, and

Two island dressings to support intravenous procedures.

We expect tangible contributions from all of these products as well as from the cumulative effect of an expanded product line. We will continue to identify and develop new products and configurations as we explore new markets and inundate existing ones.

 

Cannabis Report
UEEC
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
UEEC News: Quarterly Report (10-q) 08/20/2018 05:18:35 PM
UEEC News: Initial Statement of Beneficial Ownership (3) 08/16/2018 06:06:45 AM
UEEC News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 08/14/2018 04:03:54 PM
UEEC News: Quarterly Report (10-q) 05/21/2018 04:03:41 PM
UEEC News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 05/16/2018 11:31:17 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#1570   Thanks brother! DR5 09/17/18 09:59:35 PM
#1569   patience can be hard at times, but every dogooder 09/17/18 03:00:37 PM
#1568   Agreed! DR5 09/17/18 01:28:46 PM
#1567   Yes the FDA is most important I agree rodman 09/17/18 01:28:10 PM
#1566   Yeah, we could use more information. I DR5 09/17/18 01:24:12 PM
#1565   .72 and going up? Yes but the company rodman 09/17/18 12:00:48 PM
#1564   Nice POP! Just guessing but maybe the DR5 09/14/18 11:05:44 AM
#1563   Ya'll awake and see this jump on 38k rodman 09/14/18 10:53:46 AM
#1562   Hope your both correct and the company trys rodman 09/12/18 12:39:46 PM
#1561   Hey Rod, since United is a small company DR5 09/12/18 12:26:57 PM
#1560   Hey I hope you are correct! With FDA rodman 09/12/18 09:24:19 AM
#1559   You make me laugh sometimes Rodman. $4.50. trusttheman 09/12/18 09:10:16 AM
#1558   "This study is a prospective, non-inferiority, multi-center, randomized, rodman 09/12/18 08:27:40 AM
#1557   Hey guys/gals, I noticed in the study design DR5 09/11/18 11:17:31 AM
#1556   Hey guys/gals, I noticed in the study design DR5 09/11/18 11:17:26 AM
#1555   Looks accurate band aid. It shouldn't be. trusttheman 09/06/18 02:39:41 PM
#1554   Trust... It was I that said it was band aid 09/06/18 12:21:51 PM
#1553   Right there with you on the buying opportunity. rodman 09/06/18 11:33:41 AM
#1552   Right there with you on the buying opportunity. rodman 09/06/18 11:33:39 AM
#1551   FDA is everything Rodman. The other stuff trusttheman 09/06/18 08:05:53 AM
#1550   Pretty disappointing IMO though to see the company rodman 09/05/18 03:43:14 PM
#1549   I am sure the animal trials yielded enough dogooder 09/05/18 03:24:23 PM
#1548   Good to see Mr Jhogg has the obvious rodman 09/05/18 02:55:31 PM
#1547   My gut tells me they have already done Lonetree 09/05/18 02:53:59 PM
#1546   Good couple of posts JHOGG. I’m sure DR5 09/05/18 10:15:31 AM
#1545   One adverse issue w SurgiCel is the increase JHOGG 09/05/18 10:09:21 AM
#1544   Not necessarily. Just call it like I see JHOGG 09/05/18 10:04:45 AM
#1543   SurgiCel is THE standard hemostatic agent in surgery. JHOGG 09/05/18 10:03:29 AM
#1542   Sounds like a flipper! rodman 09/05/18 09:34:08 AM
#1541   That is a very important point. United DR5 09/04/18 07:04:20 PM
#1540   Remember when this was .08 and shot to JHOGG 09/04/18 05:21:49 PM
#1539   it says a lot when a small company dogooder 09/04/18 01:27:55 PM
#1538   Good news folks. Especially when you compare hemostyp rodman 09/04/18 12:47:43 PM
#1537   Thanks much for the info. Just scanned DR5 09/04/18 11:03:48 AM
#1536   see clinical trials .gov, it is finally real dogooder 09/04/18 10:44:15 AM
#1535   For what it’s worth, I have another limit DR5 08/28/18 03:28:07 PM
#1534   Hope it is the “Last”. Lonetree 08/28/18 03:00:08 PM
#1533   Price breakout just like the lsat run down rodman 08/28/18 02:08:04 PM
#1532   Hope you’re right about “last”. Lonetree 08/28/18 02:05:56 PM
#1531   A sad, last effort to lower the stock trusttheman 08/28/18 10:41:23 AM
#1530   Somebody dumped a bunch of shares around 10 DR5 08/27/18 04:04:43 PM
#1529   Pretty much a steal for an undervalued company IMO! rodman 08/27/18 03:54:42 PM
#1528   Well, Rodman is looking for ~$3-5 Trust is looking DR5 08/27/18 03:23:47 PM
#1527   Is that reasonably priced? Or a steal? Lonetree 08/27/18 03:19:29 PM
#1526   Just picked up another 5k @.66 DR5 DR5 08/27/18 02:08:12 PM
#1524   Primed for a rise in the pps because rodman 08/21/18 01:43:58 PM
#1523   Yeah Rod, I just finished reading the 10q DR5 08/21/18 12:04:27 PM
#1522   10Q is out and the three month period rodman 08/21/18 08:15:22 AM
#1521   Shorts are in their boiler room and at rodman 08/20/18 10:08:19 AM
#1520   Ignore the sad and pathetic trolls. They trusttheman 08/20/18 06:36:17 AM
PostSubject